Filing Details

Accession Number:
0001708138-20-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-27 16:21:32
Reporting Period:
2020-08-25
Accepted Time:
2020-08-27 16:21:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411984 P Daniel Plew Van 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp & General Mgr Industrial O No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-25 10,256 $609.71 36,854 No 4 S Direct
Common Stock Disposition 2020-08-25 7,981 $610.41 28,873 No 4 S Direct
Common Stock Disposition 2020-08-25 1,980 $611.40 26,893 No 4 S Direct
Common Stock Disposition 2020-08-25 4,044 $612.49 22,849 No 4 S Direct
Common Stock Disposition 2020-08-25 1,560 $613.62 21,289 No 4 S Direct
Common Stock Disposition 2020-08-25 1,288 $614.24 20,001 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,028 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 10,256 shares of Company stock on August 25, 2020 at prices ranging from $609.18 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  2. Represents volume-weighted average price of sales of 7,981 shares of Company stock on August 25, 2020 at prices ranging from $610.01 to $610.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 1,980 shares of Company stock on August 25, 2020 at prices ranging from $611.00 to $611.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 4,044 shares of Company stock on August 25, 2020 at prices ranging from $612.00 to $612.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 1,560 shares of Company stock on August 25, 2020 at prices ranging from $613.08 to $613.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 1,288 shares of Company stock on August 25, 2020 at prices ranging from $614.00 to $614.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.